DrugPatentWatch Database Preview
West-ward Pharms Int Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for WEST-WARD PHARMS INT, and what generic and branded alternatives to WEST-WARD PHARMS INT drugs are available?
WEST-WARD PHARMS INT has two hundred and eight approved drugs.
There are two tentative approvals on WEST-WARD PHARMS INT drugs.
Summary for West-ward Pharms Int
| US Patents: | 0 |
| Tradenames: | 142 |
| Ingredients: | 127 |
| NDAs: | 208 |
Drugs and US Patents for West-ward Pharms Int
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West-ward Pharms Int | LEVOCARNITINE | levocarnitine | INJECTABLE;INJECTION | 075567-001 | Mar 29, 2001 | AP | RX | No | No | Start Trial | Start Trial | ||||
| West-ward Pharms Int | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 065042-001 | Oct 17, 2001 | AP | RX | No | No | Start Trial | Start Trial | ||||
| West-ward Pharms Int | PROTAMINE SULFATE | protamine sulfate | INJECTABLE;INJECTION | 089475-001 | Nov 5, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| West-ward Pharms Int | NALOXONE | naloxone hydrochloride | INJECTABLE;INJECTION | 070496-001 | Sep 24, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| West-ward Pharms Int | NALOXONE | naloxone hydrochloride | INJECTABLE;INJECTION | 070298-001 | Sep 24, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for West-ward Pharms Int
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| West-ward Pharms Int | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-003 | Sep 30, 1982 | 3,947,569 | Start Trial |
| West-ward Pharms Int | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-001 | Sep 30, 1982 | 3,947,569 | Start Trial |
| West-ward Pharms Int | REGLAN | metoclopramide hydrochloride | INJECTABLE;INJECTION | 017862-004 | May 28, 1987 | 4,536,386 | Start Trial |
| West-ward Pharms Int | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-003 | Sep 30, 1982 | 4,110,438 | Start Trial |
| West-ward Pharms Int | FACTREL | gonadorelin hydrochloride | INJECTABLE;INJECTION | 018123-001 | Sep 30, 1982 | 4,110,438 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
